PARIS, FRANCE: Inventiva, a clinical-stage biopharmaceutical company, has completed sales of 2.083 million American Depositary Shares (ADS) pursuant to the company’s ATM program established on August 2, 2021, through Jefferies LLC. Each American Depositary Shares (ADS) represents one ordinary share of the company. In the ATM sales, an aggregate of 2,083,334 new American Depositary Shares…